Mental Health Clinics in Bixby, OK Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Bright Future Primary Care Of Bixby Counselor Medicare: Not Enrolled in Medicare Practice Location: 19 E Dawes Ave, Bixby, OK 74008 Phone: 918-928-5437 Fax: 888-720-8944 |
True North Life Counseling,llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 11907 S Memorial Dr Ste B, Bixby, OK 74008 Phone: 918-852-5463 |
Prophylaxis Primary Care And Behavioral Healthcare Services Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 12816 S Memorial Dr Unit 121, Bixby, OK 74008 Phone: 918-970-4719 |
News Archive
Ultrasound offers new diagnosis for whiplash injury
Lengthy waits for personal injury compensation after car crashes could be a thing of the past, thanks to research being carried out at The University of Nottingham.
Researchers reveal why granule cells and interneurons process information differently
The dentate gyrus is the "input point" for the hippocampus part of the brain. It transmits information from the short term memory to the long term. It consists of granule cells, which are especially dense in this area of the brain, and interneurons, which are linked up in the central or peripheral nervous system between several nerve cells and have an inhibiting effect on their activity. Both types of cell process information and differentiate closely-related memories.
Mymee's clinical trial demonstrates health-related quality of life improvements in lupus patients
Mymee Inc., the leading digital health company that empowers those who suffer from autoimmune disease to reclaim their health, today announced the publication of it's study assessing the Mymee Program as adjunct care in patients with Systemic Lupus Erythematosus in the Journal of Medical Internet Research .
Elusys' Anthim BLA to treat inhalational anthrax accepted for review by the FDA
Elusys Therapeutics, Inc. today announced the U.S. Food and Drug Administration has accepted for filing and review its Biologics License Application for Anthim® (obiltoxaximab) for the treatment and prevention of inhalational anthrax, a top bioterror threat which was submitted on March 20, 2015. Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government's repository of critical medical supplies for biowarfare preparedness.
Study shows over 2% positivity rate for asymptomatic pediatric dental patients tested for COVID-19
A study by a University of Illinois Chicago pediatric dentist has shown a novel way to track potential COVID-19 cases - testing children who visit the dentist. The study also showed an over 2% positivity rate for the asymptomatic children tested.
› Verified 9 days ago